Clinical trials
Terminated Leukemia, Myelogenous, Chronic, BCR-ABL Positive trials with no applicable phase
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
11 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2001 | 2 |
| 2002 | 1 |
| 2007 | 2 |
| 2009 | 2 |
| 2011 | 1 |
| 2014 | 1 |
| 2016 | 1 |
| 2021 | 1 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Terminated | 11 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Masonic Cancer Center, University of Minnesota | 3 |
| M.D. Anderson Cancer Center | 2 |
| Rex Cancer Center, Raleigh, NC | 2 |
| Emory University | 1 |
| Indiana University | 1 |
| University of California, San Francisco | 1 |
| University of Michigan Rogel Cancer Center | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Leukemia, Myelogenous, Chronic, BCR-ABL Positive | 11 |
| Leukemia, Lymphocytic, Chronic, B-Cell | 6 |
| Multiple Myeloma | 6 |
| Precursor Cell Lymphoblastic Leukemia-Lymphoma | 6 |
| Hodgkin Disease | 5 |
| Leukemia, Myeloid, Acute | 5 |
| Lymphoma, Mantle-Cell | 4 |
| Lymphoma, Non-Hodgkin | 4 |
| Anemia, Refractory, with Excess of Blasts | 3 |
| Burkitt Lymphoma | 2 |
Trials
Showing 1 to 11 of 11. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.